ArticleCancer management and research2019
Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer (ITACa) study.
Erratum issuedOpen access · goldAbstract read
In one paragraph
Article in Cancer management and research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.
0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 21 citations in OpenAlex.
- Energy Metabolism Profiling of Human Colorectal Tumours.Journal of cellular and molecular medicine · 2025Article
- Global research landscape of antiangiogenic therapy for colorectal cancer: a bibliometric analysis of mechanistic insights and clinical advancements.Frontiers in oncology · 2025Review
- A Long-term Survival Risk Prediction Model for Patients with Superficial Esophageal Squamous Cell Carcinoma.Journal of Cancer · 2024Article
- Inflammatory Response Markers as Predictors of Colorectal Cancer Prognosis.Ewha medical journal · 2023Review
- The colon inflammatory index score can predict the survival outcome after resection of colorectal cancer: a retrospective multicentre study.Journal of cancer research and clinical oncology · 2023Article
- Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab.Therapeutic advances in medical oncology · 2023Article
- Pretreatment inflammatory markers predicting treatment outcomes in colorectal cancer.Annals of coloproctology · 2022Review
- Colon inflammatory index as a useful prognostic marker after R0 resection in patients with colorectal cancer liver metastasis.PloS one · 2022Article
- Prognostic impact of the preoperatory neutrophil/lymphocyte index on early surgical complications of patients with colorectal cancer.American journal of cancer research · 2022Article
- Predictive factors of high comprehensive complication index in colorectal cancer patients using Enhanced Recovery After Surgery protocol: role as a safety net in early discharge.Annals of surgical treatment and research · 2021Article
- LDH, CRP and ALB predict nucleic acid turn negative within 14 days in symptomatic patients with COVID-19.Scottish medical journal · 2021Article
- The Prognostic Role of Early Skeletal Muscle Mass Depletion in Multimodality Management of Patients with Advanced Gastric Cancer Treated with First Line Chemotherapy: A Pilot Experience from Modena Cancer Center.Journal of clinical medicine · 2021Article
- Article
- Predictive Value of Routine Blood Test in patients with Early Esophageal Cancer: A Matched Case-Control Study.Journal of Cancer · 2021Article
- Role of a Modified Urothelium Immune Prognostic Index in Patients With Metastatic Urothelial Carcinoma Treated With Anti-PD-1/PD-L1-Based Therapy.Frontiers in molecular biosciences · 2021Article
- Gustave Roussy Immune Score as a Novel Prognostic Scoring System for Colorectal Cancer Patients: A Propensity Score Matching Analysis.Frontiers in oncology · 2021Article
- Laboratory Parameters are Possible Prognostic Markers in Patients with Advanced-stage NSCLC Treated with Bevacizumab plus Chemotherapy.Journal of Cancer · 2021Article
- Utility of neutrophil-to-lymphocyte ratio to identify long-term survivors among HCC patients treated with sorafenib.Medicine · 2020Observational
- Prognostic role of a new index (multi inflammatory index) in patients with metastatic colorectal cancer: results from the randomized ITACa trial.Therapeutic advances in medical oncology · 2020Article
Corrections and comments
- Erratum issued
Authors and funding
14 authors at 6 institutions in 1 country.
Andrea Casadei-GardiniDepartment of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Emanuela ScarpiUnit of Biostatistics and Clinical Trials, IRST IRCCS, Meldola, Italy.
Paola UliviBiosciences Laboratory, IRST IRCCS, Meldola, Italy.
Maria Angela PalladinoMedical Oncology Department, Piacenza Hospital, Piacenza, Italy.
Caterina AccetturaMedical Oncology Unit, Vito Fazzi Hospital, Lecce, Italy.
Ilaria BernardiniMedical Oncology Unit, Ramazzini Hospital, Carpi, Italy.
Andrea SpallanzaniDepartment of Oncology and Hematology, Division of Oncology, University Hospital Modena, Modena, Italy.
Fabio GelsominoDepartment of Oncology and Hematology, Division of Oncology, University Hospital Modena, Modena, Italy.
Jody CorbelliOncolgy Unit, Degli Infermi Hospital, Faenza, Italy.
Giorgia MarisiOncolgy Unit, Degli Infermi Hospital, Faenza, Italy.
Silvia RuscelliDepartment of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Martina ValgiustiDepartment of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Giovanni Luca FrassinetiDepartment of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Alessandro PassardiDepartment of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Modena and Reggio Emilia · ITIstituto Ramazzini · ITOspedale Vito Fazzi · ITOspedaliera di Piacenza · IT
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
bevacizumabfirst-linelactate dehydrogenasemetastatic colorectal cancerneutrophil-to-lymphocyte ratioprognosis
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.